AbbVie denies media reports of talks to buy Revolution Medicines
By Puyaan Singh Jan 7 (Reuters) - AbbVie on Wednesday denied it was in talks to buy Revolution Medicines after the Wall Street Journal reported the drugmaker was in advanced discussions to acquire the cancer-drug developer, citing people familiar with the matter. The company "is not in discussions with Revolution Medicines," AbbVie said in an emailed statement to Reuters. AbbVie shares were down 1.3% in extended trading, after closing 4% higher Revolution Medicines said it does not comment on r ...